Goyette, M., Cusseddu, R., Elkholi, I., Abu-Thuraia, A., El-Hachem, N., Haibe-Kains, B., . . . Côté, J. (2019). AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer. Oncotarget.
Chicago Stili AlıntıGoyette, Marie-Anne, Rebecca Cusseddu, Islam Elkholi, Afnan Abu-Thuraia, Nehme El-Hachem, Benjamin Haibe-Kains, Jean-Philippe Gratton, ve Jean-François Côté. "AXL Knockdown Gene Signature Reveals a Drug Repurposing Opportunity for a Class of Antipsychotics to Reduce Growth and Metastasis of Triple-negative Breast Cancer." Oncotarget 2019.
MLA AlıntıGoyette, Marie-Anne, et al. "AXL Knockdown Gene Signature Reveals a Drug Repurposing Opportunity for a Class of Antipsychotics to Reduce Growth and Metastasis of Triple-negative Breast Cancer." Oncotarget 2019.